298 related articles for article (PubMed ID: 11020394)
1. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia.
Fine MJ; Pratt HM; Obrosky DS; Lave JR; McIntosh LJ; Singer DE; Coley CM; Kapoor WN
Am J Med; 2000 Oct; 109(5):378-85. PubMed ID: 11020394
[TBL] [Abstract][Full Text] [Related]
2. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
3. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?
McCormick D; Fine MJ; Coley CM; Marrie TJ; Lave JR; Obrosky DS; Kapoor WN; Singer DE
Am J Med; 1999 Jul; 107(1):5-12. PubMed ID: 10403346
[TBL] [Abstract][Full Text] [Related]
4. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.
Halm EA; Fine MJ; Marrie TJ; Coley CM; Kapoor WN; Obrosky DS; Singer DE
JAMA; 1998 May; 279(18):1452-7. PubMed ID: 9600479
[TBL] [Abstract][Full Text] [Related]
5. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
[TBL] [Abstract][Full Text] [Related]
6. Length of stay has minimal impact on the cost of hospital admission.
Taheri PA; Butz DA; Greenfield LJ
J Am Coll Surg; 2000 Aug; 191(2):123-30. PubMed ID: 10945354
[TBL] [Abstract][Full Text] [Related]
7. Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China.
Zhou QT; He B; Zhu H
Value Health; 2009; 12(1):40-6. PubMed ID: 18637052
[TBL] [Abstract][Full Text] [Related]
8. Hospitalized low-risk community-acquired pneumonia: outcome and potential for cost-savings.
Hoe LK; Keang LT
Respirology; 1999 Sep; 4(3):307-9. PubMed ID: 10489681
[TBL] [Abstract][Full Text] [Related]
9. Costs associated with community acquired pneumonia in France.
Saba G; Andrade LF; Gaillat J; Bonnin P; Chidiac C; Illes HG; Laurichesse H; Messika J; Ricard JD; Detournay B; Petitpretz P; de Pouvourville G
Eur J Health Econ; 2018 May; 19(4):533-544. PubMed ID: 28547724
[TBL] [Abstract][Full Text] [Related]
10. Outcomes and costs among seniors requiring hospitalization for community-acquired pneumonia in Alberta.
Carriere KC; Jin Y; Marrie TJ; Predy G; Johnson DH
J Am Geriatr Soc; 2004 Jan; 52(1):31-8. PubMed ID: 14687312
[TBL] [Abstract][Full Text] [Related]
11. How long a stay in the hospital is needed for patients with community-acquired pneumonia?
Siegel RE
Am J Med; 2000 Oct; 109(5):434-6. PubMed ID: 11020402
[No Abstract] [Full Text] [Related]
12. Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia.
Cortoos PJ; Gilissen C; Laekeman G; Peetermans WE; Leenaers H; Vandorpe L; Simoens S
Scand J Infect Dis; 2013 Mar; 45(3):219-26. PubMed ID: 23113827
[TBL] [Abstract][Full Text] [Related]
13. Estimating the Effect of Intravenous Acetaminophen for Postoperative Pain Management on Length of Stay and Inpatient Hospital Costs.
Shaffer EE; Pham A; Woldman RL; Spiegelman A; Strassels SA; Wan GJ; Zimmerman T
Adv Ther; 2017 Jan; 33(12):2211-2228. PubMed ID: 27830448
[TBL] [Abstract][Full Text] [Related]
14. Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia.
Whittle J; Lin CJ; Lave JR; Fine MJ; Delaney KM; Joyce DZ; Young WW; Kapoor WN
Med Care; 1998 Jul; 36(7):977-87. PubMed ID: 9674616
[TBL] [Abstract][Full Text] [Related]
15. Variation in management of community-acquired pneumonia requiring admission to Alberta, Canada hospitals.
Jin Y; Marrie TJ; Carriere KC; Predy G; Houston C; Ness K; Johnson DH
Epidemiol Infect; 2003 Feb; 130(1):41-51. PubMed ID: 12613744
[TBL] [Abstract][Full Text] [Related]
16. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.
Bates DW; Spell N; Cullen DJ; Burdick E; Laird N; Petersen LA; Small SD; Sweitzer BJ; Leape LL
JAMA; 1997 Jan 22-29; 277(4):307-11. PubMed ID: 9002493
[TBL] [Abstract][Full Text] [Related]
17. Trends in mortality and medical spending in patients hospitalized for community-acquired pneumonia: 1993-2005.
Ruhnke GW; Coca-Perraillon M; Kitch BT; Cutler DM
Med Care; 2010 Dec; 48(12):1111-6. PubMed ID: 21063230
[TBL] [Abstract][Full Text] [Related]
18. Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients.
Kahn JM; Rubenfeld GD; Rohrbach J; Fuchs BD
Med Care; 2008 Dec; 46(12):1226-33. PubMed ID: 19300312
[TBL] [Abstract][Full Text] [Related]
19. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay.
Allman RM; Goode PS; Burst N; Bartolucci AA; Thomas DR
Adv Wound Care; 1999; 12(1):22-30. PubMed ID: 10326353
[TBL] [Abstract][Full Text] [Related]
20. Resource utilization of adults admitted to a large urban hospital with community-acquired pneumonia caused by Streptococcus pneumoniae.
Sun HK; Nicolau DP; Kuti JL
Chest; 2006 Sep; 130(3):807-14. PubMed ID: 16963679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
